Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 14.2B | 15.1B | 14.5B | 13.4B |
Cost of revenue | 11.9B | 12.5B | 12.2B | 11.4B |
Gross profit | 2.2B | 2.6B | 2.3B | 2.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.3B | 1.4B | 1.3B | 1.2B |
Operating income | 888M | 1.2B | 970.4M | 839M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 200.3M | 206.1M | 208M | 209.5M |
Other income expense | — | — | — | — |
Pretax income | 810.4M | 1.1B | 849.1M | 720.3M |
Tax provision | 258.9M | 282.5M | 220.7M | 186.1M |
Net income | 551.5M | 810.1M | 628.4M | 534.2M |
Basic EPS | — | 34.1 | 26.5 | 22.5 |
Diluted EPS | — | 34.1 | 26.5 | 22.5 |
Basic average shares | — | 23.7M | 23.7M | 23.7M |
Diluted average shares | — | 23.7M | 23.7M | 23.7M |
EBITDA | 1.0B | 1.3B | 1.1B | 929.8M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |